These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 24387716

  • 21. Emu Oil Combined with Lyprinol™ Reduces Small Intestinal Damage in a Rat Model of Chemotherapy-Induced Mucositis.
    Mashtoub S, Lampton LS, Eden GL, Cheah KY, Lymn KA, Bajic JE, Howarth GS.
    Nutr Cancer; 2016 Oct; 68(7):1171-80. PubMed ID: 27618153
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Differential Effectiveness of Clinically-Relevant Analgesics in a Rat Model of Chemotherapy-Induced Mucositis.
    Whittaker AL, Lymn KA, Wallace GL, Howarth GS.
    PLoS One; 2016 Oct; 11(7):e0158851. PubMed ID: 27463799
    [Abstract] [Full Text] [Related]

  • 24. Animal models of mucositis: implications for therapy.
    Bowen JM, Gibson RJ, Keefe DM.
    J Support Oncol; 2011 Oct; 9(5):161-8. PubMed ID: 22024303
    [Abstract] [Full Text] [Related]

  • 25. Serum Bovine Immunoglobulin for Chemotherapy-Induced Gastrointestinal Mucositis.
    Arikapudi S, Rashid S, Al Almomani LA, Treece J, Baumrucker SJ.
    Am J Hosp Palliat Care; 2018 May; 35(5):814-817. PubMed ID: 29020798
    [Abstract] [Full Text] [Related]

  • 26. Roles of growth factors in chemotherapy-induced intestinal mucosal damage repair.
    Xian CJ.
    Curr Pharm Biotechnol; 2003 Aug; 4(4):260-9. PubMed ID: 14529428
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Anti-inflammatory agents in the management of alimentary mucositis.
    Lalla RV, Schubert MM, Bensadoun RJ, Keefe D.
    Support Care Cancer; 2006 Jun; 14(6):558-65. PubMed ID: 16565821
    [Abstract] [Full Text] [Related]

  • 29. Palifermin in the management of mucositis in hematological malignancies: current evidences and future perspectives.
    Niscola P, Scaramucci L, Giovannini M, Ales M, Bondanini F, Cupelli L, Dentamaro T, Lamanda M, Natale G, Palumbo R, Romani C, Tendas A, Tolu B, Violo L, de Fabritiis P.
    Cardiovasc Hematol Agents Med Chem; 2009 Oct; 7(4):305-12. PubMed ID: 19607642
    [Abstract] [Full Text] [Related]

  • 30. Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice.
    Peterson DE, Keefe DM, Hutchins RD, Schubert MM.
    Support Care Cancer; 2006 Jun; 14(6):499-504. PubMed ID: 16775646
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Risk analysis, diagnosis and management of gastrointestinal mucositis in pediatric cancer patients.
    Kuiken NS, Rings EH, Tissing WJ.
    Crit Rev Oncol Hematol; 2015 Apr; 94(1):87-97. PubMed ID: 25560731
    [Abstract] [Full Text] [Related]

  • 33. The role of mucins in mucositis.
    Thorpe D.
    Curr Opin Support Palliat Care; 2019 Jun; 13(2):114-118. PubMed ID: 30893104
    [Abstract] [Full Text] [Related]

  • 34. New strategies for management of oral mucositis in cancer patients.
    Peterson DE.
    J Support Oncol; 2006 Feb; 4(2 Suppl 1):9-13. PubMed ID: 16499139
    [Abstract] [Full Text] [Related]

  • 35. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.
    Logan RM, Stringer AM, Bowen JM, Yeoh AS, Gibson RJ, Sonis ST, Keefe DM.
    Cancer Treat Rev; 2007 Aug; 33(5):448-60. PubMed ID: 17507164
    [Abstract] [Full Text] [Related]

  • 36. The role of alternative and natural agents, cryotherapy, and/or laser for management of alimentary mucositis.
    Migliorati CA, Oberle-Edwards L, Schubert M.
    Support Care Cancer; 2006 Jun; 14(6):533-40. PubMed ID: 16572313
    [Abstract] [Full Text] [Related]

  • 37. Gastrointestinal mucositis: focus on the treatment of the effects of chemotherapy and radiotherapy on the rectum.
    Zur E.
    Int J Pharm Compd; 2012 Jun; 16(2):117-24. PubMed ID: 23050323
    [Abstract] [Full Text] [Related]

  • 38. Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage.
    Bowen JM, Gibson RJ, Cummins AG, Keefe DM.
    Support Care Cancer; 2006 Jul; 14(7):713-31. PubMed ID: 16453135
    [Abstract] [Full Text] [Related]

  • 39. Understanding chemotherapy-induced intestinal mucositis and strategies to improve gut resilience.
    Sougiannis AT, VanderVeen BN, Davis JM, Fan D, Murphy EA.
    Am J Physiol Gastrointest Liver Physiol; 2021 May 01; 320(5):G712-G719. PubMed ID: 33471628
    [Abstract] [Full Text] [Related]

  • 40. Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications.
    Touchefeu Y, Montassier E, Nieman K, Gastinne T, Potel G, Bruley des Varannes S, Le Vacon F, de La Cochetière MF.
    Aliment Pharmacol Ther; 2014 Sep 01; 40(5):409-21. PubMed ID: 25040088
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.